Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) With or Without Rituximab in Previously Treated Chronic Lymphocytic Leukemia

NCT00337246 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00337246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00337246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) With or Without Rituximab in Previously Treated Chronic Lymphocytic Leukemia
Lead sponsor
Cancer Research UK
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
March 31, 2011
Enrollment
56 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia